|

Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer

RECRUITINGN/ASponsored by Gustave Roussy, Cancer Campus, Grand Paris
Actively Recruiting
PhaseN/A
SponsorGustave Roussy, Cancer Campus, Grand Paris
Started2026-05-04
Est. completion2027-09
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol). It assesses the impact of a digital intervention (based on the use of the Open Food Facts app) as a complement to the nutritional education provided by the Interception program.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age \> 18 years,
2. Individuals at increased risk of different cancers as defined within the Interception program,
3. With a baseline WCRF score ≤ 5 at entry in the Interception program,
4. Agreeing to participate and who have given their written agreement for the study,
5. Agreeing to fill in the questionnaires on the dedicated platform for the duration of the study,
6. Participant have and accept to use their smartphone,
7. All participants must understand spoken and written French language

Exclusion Criteria:

1. Psychiatric disorders or cognitive impairments precluding participation,
2. Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.

Conditions7

Breast CancerCancerColon CancerGermline BRCA1 Gene MutationGermline BRCA2 Gene MutationLynch SyndromePancreas Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.